Show simple item record

dc.contributor.authorLangendorf, C
dc.contributor.authorLastrucci, C
dc.contributor.authorSanou-Bicaba, I
dc.contributor.authorBlackburn, K
dc.contributor.authorKoudika, MH
dc.contributor.authorCrucitti, T
dc.date.accessioned2019-02-14T14:34:30Z
dc.date.available2019-02-14T14:34:30Z
dc.date.issued2018-12-22
dc.date.submitted2019-02-01
dc.identifier.citationDual screen and confirm rapid test does not reduce overtreatment of syphilis in pregnant women living in a non-venereal treponematoses endemic region: a field evaluation among antenatal care attendees in Burkina Faso. 2018 Sex Transm Infecten
dc.identifier.issn1472-3263
dc.identifier.pmid30580325
dc.identifier.doi10.1136/sextrans-2018-053722
dc.identifier.urihttp://hdl.handle.net/10144/619336
dc.description.abstractIn resource-limited settings, screening pregnant women for syphilis using rapid diagnostic tests (RDTs) is a key tool in the prevention of congenital syphilis. However, most syphilis RDTs detect only treponemal antibodies (T-RDT), meaning antibiotics may be provided unnecessarily to previously treated pregnant women, particularly in non-venereal treponematoses endemic regions. We estimated the potential reduction in overtreatment when comparing T-RDT (SD Bioline) to a newer rapid test (Dual Path Platform (DPP) Screen and Confirm Assay, Chembio) detecting both treponemal and non-treponemal antibodies.
dc.language.isoenen
dc.publisherBMJ Publishing Groupen
dc.rightsPublished by BMJ Publishing Groupen
dc.titleDual Screen and Confirm Rapid Test Does Not Reduce Overtreatment of Syphilis in Pregnant Women Living in a Non-venereal treponematoses Endemic Region: a Field Evaluation Among Antenatal Care Attendees in Burkina Fasoen
dc.identifier.journalSexually Transmitted Infectionsen
refterms.dateFOA2019-03-04T14:18:33Z
html.description.abstractIn resource-limited settings, screening pregnant women for syphilis using rapid diagnostic tests (RDTs) is a key tool in the prevention of congenital syphilis. However, most syphilis RDTs detect only treponemal antibodies (T-RDT), meaning antibiotics may be provided unnecessarily to previously treated pregnant women, particularly in non-venereal treponematoses endemic regions. We estimated the potential reduction in overtreatment when comparing T-RDT (SD Bioline) to a newer rapid test (Dual Path Platform (DPP) Screen and Confirm Assay, Chembio) detecting both treponemal and non-treponemal antibodies.


Files in this item

Thumbnail
Name:
Langendorf et al - 2018 - Dual ...
Size:
157.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record